LBX Pharmacy Chain JSC banner

LBX Pharmacy Chain JSC
SSE:603883

Watchlist Manager
LBX Pharmacy Chain JSC Logo
LBX Pharmacy Chain JSC
SSE:603883
Watchlist
Price: 14 CNY -0.78% Market Closed
Market Cap: ¥10.6B

P/FCFE

4.2
Current
34%
Cheaper
vs 3-y average of 6.4

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
4.2
=
Market Cap
¥10.6B
/
Free Cash Flow to Equity
¥2.5B

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
4.2
=
Market Cap
¥10.6B
/
Free Cash Flow to Equity
¥2.5B

Valuation Scenarios

LBX Pharmacy Chain JSC is trading below its 3-year average

If P/FCFE returns to its 3-Year Average (6.4), the stock would be worth ¥21.23 (52% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+521%
Average Upside
233%
Scenario P/FCFE Value Implied Price Upside/Downside
Current Multiple 4.2 ¥14
0%
3-Year Average 6.4 ¥21.23
+52%
5-Year Average 7.9 ¥26.1
+86%
Industry Average 15.8 ¥51.96
+271%
Country Average 26.4 ¥87.01
+521%

Forward P/FCFE
Today’s price vs future free cash flow to equity

Not enough data available to calculate forward P/FCFE

Peer Comparison

All Multiples
P/FCFE
P/E
All Countries
Close

Market Distribution

Lower than 91% of companies in China
Percentile
9th
Based on 5 086 companies
9th percentile
4.2
Low
0.2 — 13.7
Typical Range
13.7 — 52.8
High
52.8 —
Distribution Statistics
China
Min 0.2
30th Percentile 13.7
Median 26.4
70th Percentile 52.8
Max 2 279 450.9

LBX Pharmacy Chain JSC
Glance View

Market Cap
10.6B CNY
Industry
Retail

LBX Pharmacy Chain JSC has emerged as a significant player in the pharmaceutical retail sector in China, riding the wave of increasing health consciousness and the aging population. Founded in a fast-paced, constantly evolving market, the company has strategically positioned itself to leverage this demographic shift. Its primary business model revolves around operating an extensive network of pharmacy outlets that serve both urban and rural customers. By offering a wide range of products, from prescription medications to health supplements and wellness goods, LBX ensures it caters to a diverse clientele, satisfying varying health care needs. The implementation of an omnichannel approach, integrating online and offline sales, has not only enhanced customer convenience but also expanded its reach, reinforcing its market position. Central to LBX’s profitability is its efficient supply chain management and strategic location of stores in high-traffic areas, which augments its accessibility and stock management capabilities. The company leverages partnerships with leading pharmaceutical manufacturers and distributors, securing competitive pricing and product availability. Additionally, its investment in technology bolsters its operational efficiency, enabling real-time inventory tracking and personalized customer service. This tech-driven approach enhances customer loyalty and provides insights into consumer behavior, guiding strategic decisions. Through a well-crafted blend of traditional retail expertise and innovative solutions, LBX Pharmacy Chain JSC continues to solidify its foothold in the market, driving revenue growth and expanding its reach across China.

Intrinsic Value
31.07 CNY
Undervaluation 55%
Intrinsic Value
Price ¥14
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett